Lineage Cell Therapeutics Inc. — Remuneration Information 2021

Sep 2, 2021

SUPPLEMENTAL INFORMATION REGARDING PROPOSAL 4 � APPROVAL OF THE LINEAGE CELL THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN.���� ���� ���� ����� ��' false

������' �� ��������� ����	2 380
.LINEAGE CELL THERAPEUTICS, INC
Corporation no: 876343	10834
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	02/09/2021
	www.isa.gov.il			www.tase.co.il				Reference:	2021-02-143730	Time of broadcast: 13:29 13:29

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onSUPPLEMENTAL INFORMATION REGARDING PROPOSAL 4 � APPROVAL OF THE LINEAGE CELL THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN. ���� ���� ���� ����� ��' 4 - ����� ������ ������� �����.

14A_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 10/08/2021
Address: HARBOR BAY PARKWAY 1301 , ALAMEDA 94502   CALIFORNIA , U.S.A Tel: 5105213390 , Fax: 5105213389
E-mail address: info@biotimeinc.com   Company site: biotimeinc.com
Previous names of reporting entity: .BIOTIME, INC
Name of the Signatory: Gerzi Ilan Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company: PEARL COHEN ZEDEK LATZER BARATZ
Address: Derech Menachem Begin 132 , Tel-Aviv 6702101 Telephone: 03-6073777 Facsimile: 03-6073778 E-mail: Igerzi@pearlcohen.com 1
U.S.A